<DOC>
	<DOCNO>NCT00865397</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study evaluate glycaemic control subject type 2 diabetes use daily Levemir® initiation insulin therapy Hungary .</brief_summary>
	<brief_title>Observational Study Type 2 Diabetics Failing Oral Antidiabetic Therapy Starting Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Patient type 2 diabetes inadequately control OAD therapy base discretion individual physician Patient willing sign inform consent Particular attention pay age limit , indication contraindication drug interaction list within product label Subjects diagnose type 1 diabetes mellitus Subjects unlikely comply observational plan , ( e.g. , uncooperative attitude , inability return visit ) Subjects hypersensitivity Levemir® ingredient Women childbearing potential , pregnant , breastfeed intend become pregnant within next 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>